Morning Overview

Diet-soda sweeteners nudged up blood-sugar control markers in a review of 21 trials

A new analysis pooling results from 21 randomized trials found that low- and no-calorie sweeteners, the kind used in diet sodas, were associated with small increases in markers of blood-sugar control rather than the neutral effect many consumers assume. Researchers at Tufts University report that these sweeteners raised fasting insulin and HbA1c compared with non-caloric controls such as water or placebo, and showed a trend toward worsening insulin sensitivity.

Why the comparison matters

Much of the confusion around artificial sweeteners stems from what they are being measured against. Compared with sugar, a diet soda plainly delivers fewer calories, which is why sweeteners are often assumed to be metabolically harmless. This analysis takes a different approach by comparing the sweeteners with non-caloric controls, meaning water or placebo rather than sugar. That choice is deliberate, because it isolates the direct physiological effect of the sweetener itself rather than the benefit of avoiding sugar’s calories.

Under that stricter comparison, the picture shifts. The researchers found that the sweeteners were associated with higher fasting insulin and higher HbA1c, a marker that reflects longer-term blood-sugar control, along with a trend toward reduced insulin sensitivity. In plain terms, the substances that were supposed to be inert appeared to nudge several markers in an unfavorable direction when the calorie-replacement advantage was stripped out of the equation.

That distinction is the crux of the finding. It does not claim diet soda is worse than regular soda; it claims that, judged on their own biological effects rather than as a sugar substitute, these sweeteners are not simply neutral. For anyone who switched to diet drinks expecting a metabolic free pass, that is a meaningful reframing.

What the review examined

The work drew on 21 randomized clinical trials in adults, pooling their results to detect patterns that individual studies might be too small to reveal. The analysis was conducted by researchers from the Food is Medicine Institute at Tufts University’s Friedman School of Nutrition Science and Policy and was published in the journal Current Atherosclerosis Reports, according to the university’s own account and coverage of the findings.

By restricting the comparison to non-caloric controls, the authors say they were better able to isolate the direct effects of the sweeteners rather than the calories they replace. When the results across trials were combined, the researchers found signals that the compounds may carry metabolic harms, expressed through the changes in insulin and HbA1c described above.

One proposed mechanism involves the gut. The researchers note that non-nutritive sweeteners generally pass through the digestive tract and come into direct contact with gut microbes, and disruption of that microbial community is one hypothesis for how a substance with essentially no calories could still influence blood-sugar regulation. That explanation is offered as a possibility, not a proven pathway.

How much weight to give the results

Context and proportion matter here. The effects described are increases in laboratory markers, fasting insulin, HbA1c, and a trend in insulin sensitivity, rather than documented cases of disease, and the coverage reviewed does not quantify how large those increases were in absolute terms. A statistically detectable shift in a marker is not the same as a clinically dramatic change, and readers should be careful not to inflate the finding beyond what the data support.

At the same time, the analysis adds to a growing body of research questioning the assumption that sugar substitutes are metabolically inert, and it does so using pooled randomized trials, which are a stronger form of evidence than single observational studies. The gut-microbiome explanation remains a hypothesis, and the exact magnitude of the effects is not detailed in the available summary, so this is best read as a reason for measured caution rather than alarm.

For a reader, the practical takeaway is modest and specific. The finding does not endorse switching back to full-sugar drinks, which carry their own well-established risks, and it does not establish that diet sodas cause diabetes. What it does suggest is that reaching for water instead of a sweetened beverage, diet or otherwise, is the choice the analysis’s own control group represents. Anyone managing blood sugar or weighing beverage choices for health reasons has grounds to treat “zero calorie” as less automatically beneficial than the marketing implies, and to raise the question with a clinician if it bears on their care.

More from Morning Overview


*This article was researched with the help of AI, with human editors creating the final content.